AlzBiomarker
MCI-AD vs MCI-Stable: neurogranin (CSF)
Baseline levels of the synaptic protein neurogranin appear to be higher in people with mild cognitive impairment who went on to develop Alzheimer’s dementia than in those who did not decline at follow-up. However, this meta-analysis is limited to four studies, and the p value is only marginally significant.
Loading data...